Effects of zoledronic acid and ibandronic acid on renal functions and calcium, phosphorus and alkaline phosphatase levels in breast cancer patients with bone metastases: a retrospective analysis
Kategorie:
Pierś
Przewód pokarmowy
Mięsaki tkanek miękkich, kości i GIST
Układ moczowo-płciowego
Gruczoły wydzielania wewnętrznego
Płuco i opłucna
Inne
Narządy głowy i szyi
Ginekologia onkologiczna
Czerniak
Gruczoł krokowy
Terapia wspomagająca
Działy:
Doniesienia naukowe
Aktualności Bone is a common site of metastasis in patients with breast cancer. Skeletal complications associated with bone metastasis are commonly treated with bisphosphonates. However, there are a number of side-effects associated with these, such as renal failure, hypocalcemia and osteonecrosis of the jaw. We aimed to determine the effects of ibandronic and zoledronic acid on serum creatinine (SCr), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP) and estimated glomerular filtration rates (eGFR). The objective was to determine the safety of these bisphosphonates, especially zoledronic acid.
